Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phenol, also known as carbolic acid, is a simple aromatic organic compound (C6H5OH) and is not a therapeutic target (such as a receptor or enzyme) in the human body. Instead, it is a chemical substance used as a pharmaceutical agent, antiseptic, and disinfectant [8]. In clinical practice, phenol is primarily utilized for neurolysis to treat severe muscle spasticity, where it acts by non-specifically denaturing proteins and causing localized nerve destruction [8]. It is also used in chemical matrixectomy for ingrown toenails and as a preservative in certain vaccines [8]. While many drugs contain phenolic functional groups that are essential for binding to specific biological targets, phenol itself lacks the specificity required to be a drug target [7, 9]. Its use is limited by significant safety concerns, including its corrosive nature and potential for systemic toxicity affecting the central nervous system and cardiovascular system [8]. Consequently, it is classified as a chemical agent rather than a biological target for drug development.
Not applicable; Phenol is a chemical compound and pharmaceutical agent, not a biological target for other drugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phenol.